Mihail Obrocea - 31 May 2023 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Chief Medical Officer
Signature
/s/ Mihail Obrocea
Issuer symbol
MAIA
Transactions as of
31 May 2023
Transactions value $
$0
Form type
4
Filing time
05 Jun 2023, 17:23:44 UTC
Previous filing
10 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Stock Options Award $0 +87.5K $0.00 87.5K 31 May 2023 Common Stock 87.5K $2.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options, granted on May 31, 2023 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.